Rep. Marjorie Taylor Greene has disclosed two stock purchases drawing fresh scrutiny after both positions rose immediately following her trades.
In a filing submitted on November 13, 2025, Greene revealed she bought shares of Automatic Data Processing (ADP) and Paychex (PAYX) on November 12, with each purchase valued between $15,001 and $50,000.
Market data shows that since Greene’s trades, ADP has climbed 1.08%, while Paychex has risen more than 2.5%.
Marjorie Taylor Greene’s stock trades. Source: CongressAlthough members of Congress are permitted to trade individual stocks, both companies operate in sectors that intersect directly with Greene’s committee responsibilities.
As a member of the House Homeland Security and Oversight Committees, she has oversight related to workforce security, data protection, digital infrastructure, and business continuity, areas where ADP and Paychex are key players.
Receive Signals on US Congress Members’ Stock Trades
Stocks
Stay up-to-date on the trading activity of US Congress members. The signal triggers based on updates from the House disclosure reports, notifying you of their latest stock transactions.
Enable signal
Greene’s controversial stock trades
Notably, Greene’s Congress trading history has repeatedly drawn attention. Earlier this year, she purchased Palantir (NASDAQ: PLTR) shares just days before the company secured a major federal contract with ICE, a deal tied to national-security issues overseen by her committee.
She also made a cluster of trades around the announcement of President Donald Trump’s temporary tariff pause while simultaneously moving tens of thousands of dollars out of Treasury bills.
Watchdogs said the timing appeared unusually aligned with market-moving policy decisions. However, the politician has maintained that her financial adviser makes the trades independently, but critics argue that delegation does little to eliminate potential conflicts of interest.
Her record also includes buying Lockheed Martin stock just days before Russia’s full-scale invasion of Ukraine, sparking “war profiteering” allegations. She has held stakes in major vaccine makers while publicly criticizing COVID-19 vaccinations, raising additional transparency concerns.
Featured image via Shutterstock
Source: https://finbold.com/marjorie-taylor-greene-makes-2-super-suspicious-stock-trades/
